
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
Bagsværd, Denmark, 7 November 2023 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated persons in accordance with Article 19 of Regulation No. 596/2014 on market abuse.
The company’s board members, executives and their associated persons have given Novo Nordisk power of attorney on their behalf to publish trading in Novo Nordisk shares by the company’s board members, executives and their associated persons.
Please find below a statement of such trading in shares issued by Novo Nordisk.
1 | Details of the person discharging managerial responsibilities/person closely associated | ||||
a) | Name of the Board member/Executive/Associated Person | Henrik Wulff | |||
2 | Reason for the notification | ||||
a) | Position/status | Executive Vice President, head of Product Supply, Quality & IT | |||
b) | Initial notification/Amendment | Initial notification | |||
3 | Details of the issuer | ||||
a) | Name | Novo Nordisk A/S | |||
b) | LEI | 549300DAQ1CVT6CXN342 | |||
4 | Details of the transaction(s) | ||||
a) | Description of the financial instrument, type of instrument, | Shares | |||
Identification code | Novo Nordisk B DK0062498333 | ||||
b) | Nature of the transaction | Sale of shares | |||
c) | Price(s) and volume(s) | ||||
Price(s) | Volume(s) | ||||
DKK 686.03 | 20,000 shares | ||||
d) | Aggregated information
| 20,000 shares DKK 13,720,600 | |||
e) | Date of the transaction | 2023-11-06 | |||
f) | Place of the transaction | Nasdaq Copenhagen |
Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases, built upon our heritage in diabetes. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease. Novo Nordisk employs about 61,400 people in 80 countries and markets its products in around 170 countries. Novo Nordisk's B shares are listed on Nasdaq Copenhagen (Novo-B). Its ADRs are listed on the New York Stock Exchange (NVO). For more information, visit novonordisk.com,Facebook, Instagram, X, LinkedIn andYouTube.
Contacts for further information
Media: | |
Ambre James-Brown +45 3079 9289 abmo@novonordisk.com | Elizabeth DeLuca (US) +1 609 580 9868 edel@novonordisk.com |
Investors: | |
Daniel Muusmann Bohsen +45 3075 2175 dabo@novonordisk.com | Jacob Martin Wiborg Rode +45 3075 5956 jrde@novonordisk.com |
David Heiberg Landsted +45 3077 6915 dhel@novonordisk.com | Mark Joseph Root (US) +1 848 213 3219 mjhr@novonordisk.com |
Sina Meyer +45 3079 6656 azey@novonordisk.com | Frederik Taylor Pitter +45 3075 8259 fptr@novonordisk.com |
Company Announcement No 74 / 2023
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Finanskalender for 20247.12.2023 10:29:26 CET | pressemeddelelse
Meddelelse nr. 11 - 2023 til Nasdaq Copenhagen 7. december 2023 Finanskalender for 2024 Bestyrelsen for BRØDRENE A & O JOHANSEN A/S har vedtaget følgende finanskalender for 2024: Frist for aktionærer for fremsættelse af emner på dagsordenen til den ordinære generalforsamling: 6. februar 2024 Årsrapport for 2023: 21. februar 2024 Ordinær generalforsamling: 20. marts 2024 Delårsrapport for 1. kvartal 2024: 24. april 2024 Delårsrapport for 1. halvår 2024: 14. august 2024 Delårsrapport for 1.-3. kvartal 2024: 23. oktober 2024 Yderligere information fås hos: Adm. direktør Niels A. Johansen Finansdirektør/viceadm. direktør Per Toelstang Brødrene A & O Johansen A/S Rørvang 3 2620 Albertslund Tlf.: 70 28 00 00 Med venlig hilsen BRØDRENE A & O JOHANSEN A/S Niels A. Johansen Vedhæftet fil Finanskalender for 2024
Notification of managers and closely related parties’ transactions with A.P. Møller - Mærsk A/S shares in connection with share buy-back program7.12.2023 09:36:29 CET | Press release
In connection with the announced share buy-back program in A.P. Møller - Mærsk A/S, A.P. Møller Holding A/S continuously sells shares pro rata and the market is to be informed accordingly – see the attached file. Attachment APMM Share buy-back APMH sale 06122023
Indberetning af ledende medarbejderes og disses nærtståendes transaktioner med A.P. Møller - Mærsk A/S aktier i forbindelse med aktietilbagekøbsprogram7.12.2023 09:36:29 CET | pressemeddelelse
I forbindelse med det annoncerede aktietilbagekøbsprogram i A.P. Møller - Mærsk A/S sælger A.P. Møller Holding A/S løbende aktier pro rata og markedet informeres følgeligt herom - se vedhæftede fil. Vedhæftet fil APMM Aktietilbagekøbsprogram APMH salg_06122023
Change in the composition of Sydbank’s Group Executive Management7.12.2023 09:15:00 CET | Press release
Company Announcement No 42/2023 Peberlyk 4 6200 Aabenraa, Denmark Tel +45 70 10 78 79 Fax +45 74 37 35 36 Sydbank A/S CVR No DK 12626509, Aabenraa sydbank.dk 7 December 2023 Dear Sirs Change in the composition of Sydbank’s Group Executive Management The position of Deputy Group Chief Executive with responsibility for Credits and Compliance etc. is handed over to a new member of the Group Executive Management from the Bank’s own ranks. Member of the Group Executive Management and Deputy Group Chief Executive Bjarne Larsen resigns from his position in this connection. Sydbank’s current Group Executive Vice President, Credits, Stig Westergaard, is appointed as Deputy Group Chief Executive with responsibility for Credits and Compliance etc. - The Board of Directors has decided to change the composition of the Group Executive Management. We wished to make a change with a new person in the important role as the officer in charge of Credits and Compliance. We find that Sydbank’s current Group
Sydbank ændrer sammensætningen i direktionen7.12.2023 09:15:00 CET | pressemeddelelse
Selskabsmeddelelse nr. 42/2023 Peberlyk 4 DK-6200 Aabenraa Telefon +45 70 10 78 79 Telefax +45 74 37 35 36 Sydbank A/S CVR-nr. DK 12626509, Aabenraa sydbank.dk 7. december 2023 Sydbank ændrer sammensætningen i direktionen Posten som bankdirektør med ansvar for bl.a. kredit og compliance bliver overdraget til nyt direktionsmedlem, der er fundet internt. Direktionsmedlem og bankdirektør Bjarne Larsen fratræder i den forbindelse. Sydbanks nuværende kreditdirektør Stig Westergaard udnævnes til bankdirektør med ansvar for bl.a. kredit og compliance. - Bestyrelsen har besluttet at ændre ved sammensætningen i direktionen. Vi har ønsket at gennemføre et skifte, med en ny person på den vigtige post som kredit og complianceansvarlig. Her har vi fundet, at Sydbanks nuværende kreditdirektør Stig Westergaard er et stærkt valg for området og banken. I bestyrelsen kender vi Stig Westergaard som en kompetent og meget behagelig samarbejdspartner, siger bestyrelsesformand Lars Mikkelgaard-Jensen. Farvel